C84.7B Anaplastic large cell lymphoma, ALK-negative, in remission
C84.7B is a risk-adjusting diagnosis under CMS-HCC and RxHCC models. Create a free account to see model versions, RAF contribution, and AI-powered HCC suppression analysis.
Get what a quick lookup can't: the AI assistant for official-guideline questions, HCC risk-adjustment mappings (CMS-HCC V24/V28, RxHCC), FDA drug indications, and AHA Coding Clinic references for C84.7B.
The ICD-10-CM code for Anaplastic large cell lymphoma, ALK-negative, in remission is C84.7B (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Chapter
- 2: Neoplasms (C00-D49)
- Section
- C81-C96: Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
- Category C84
- 98 codes (89 billable)
- FY2026 Status
- Introduced in FY2025
Official Coding Guidelines
BIA-ALCL code assignment; do not code as ch. 19 complications. Breast Implant Associated Anaplastic Large Cell Lymphoma Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) is a type of lymphoma that can develop around breast implants. Assign code C84.7A, Anaplastic large cell lymphoma, ALK-negative, breast, for BIA-ALCL or C84.7B, Anaplastic large cell lymphoma, ALK-negative, in remission, for BIA- ALCL in remission. Do not assign a complication code from chapter 19.
Tx of primary site (TOC entry)a. Admission/Encounter for treatment of primary site ............................................................. 33
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026
References
Cite This Page
Reference C84.7B with the canonical source and edition:
C84.7B — Anaplastic large cell lymphoma, ALK-negative, in remission. ICD-10 Coding Pro (ICD-10-CM FY2026). https://icd10codingpro.com/codes/C84.7B
Canonical URL: https://icd10codingpro.com/codes/C84.7B